The WEL Research Institute is an inter-university research institute based in Wallonia, whose mission is to support strategic research of excellence. Its WELBIO department funds research programs in the life sciences, and promotes the valorization of scientific results into medical, pharmaceutical and veterinary biotechnological applications.
A
hrough this funding, Wallonia grants significant resources over several years to WELBIO Investigators within the WEL Research Institute to enable them to develop ambitious research programs and achieve new scientific breakthroughs. WEL Research Institute Investigators must demonstrate their scientific excellence, their knowledge of the medical and technological needs in their field, and their willingness to look for opportunities to apply their discoveries.
New funding
| Principal Investigator | Project title | Instrument & period |
|---|---|---|
| Bénédicte Machiels | Pneumovirus infections induce long-lasting alterations in host immunity, favoring the development of lung cancers |
WELBIO - STARTING GRANT 2024 - 2026 |
| CHARIOT Alain | Reprogramming protein synthesis via chemical modifications of transfer RNAs in human pathologies |
WELBIO - ADVANCED GRANT 2024 - 2026 |
| Benjamin G. DEWALS | Identification of mechanisms regulating the effector functions of virtual memory T lymphocytes during helminthic and viral co-infections |
WELBIO - ADVANCED GRANT 2024 - 2026 |
Funding in progress
| Pierre CLOSE | The epitranscriptomics of transfer RNAs: a new cancer vulnerability |
ADVANCED GRANT 2022-2026 |
| Thomas MARICHAL | Deciphering the contribution of the myeloid-epithelial axis to exacerbations of chronic lung disease: a key route to precision medicine and improved quality of life |
ADVANCED GRANT 2022-2026 |
| Michel Georges |
Identification of IBD susceptibility genes and interacting drugs by systematic eQTL and CMap analysis. |
ADVANCED GRANT 2022-2026 |
| Laurent NGUYEN |
Cell migration shapes morphogenesis and function of the cerebral cortex |
ADVANCED GRANT 2022-2026 |
| Alain VANDERPLASSCHEN |
Using herpesvirus-fish models to study host-pathogen-environment interactions: a new approach to disease control in aquaculture |
ADVANCED GRANT 2022-2026 |
| Francesca RAPINO |
Becoming cancerous: the role of tRNA players in the establishment of cancer stem cells |
STARTING GRANT 2022-2026 |
| Agnès NOËL |
Innovative roles for uPARAP in lymphatic vessel morphogenesis and function |
ADVANCED GRANT 2019-2024 |
| CHARIOT Alain | Roles of transfer RNA-modifying enzymes in immune response and tumor development |
CONTINUATION GRANT 2019-2024 |
| BUREAU Fabrice | Lung regulatory macrophages: phenotype, function and therapeutic potential |
WELBIO - CONTINUATION GRANT 2017-2021 |
| CLOSE Pierre | THERAtRAME Involvement of translation reprogramming via tRNA floating base modification in cancers |
STARTING GRANT 2017-2022 |
| MARICHAL Thomas | MUCOSAGUARD Epithelial cells as major regulators of mucosal homeostasis: study of the regulatory role of Rab guanine nucleotide exchange factor-1 (RABGEF1). |
STARTING GRANT 2017-2022 |
| CHARIOT Alain | Dissecting oncogenic pathways Study of ELP3 and KIAA1199 proteins in tumor development and resistance to targeted therapies |
ADVANCED GRANT 2015-2019 |
| DESMET Christophe | Translational regulation of T cells Translational regulation of T cell hematopoiesis and differentiation |
STARTING GRANT 2015-2019 |
| VAN STEEN Kristel | DESTINCT Detection of statistical interactions in complex traits |
STARTING GRANT 2015-2019 |
